AA amyloidosis associated with pulmonary squamous cell carcinoma treated with chemoradiation and immune checkpoint inhibitor therapy-Reference-Cited by-同舟云学术

AA amyloidosis associated with pulmonary squamous cell carcinoma treated with chemoradiation and immune checkpoint inhibitor therapy

Published:2020-03-02 Issue:5 Volume:70 Page:303-305
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:Pathol Int

Author:

Mo Huan¹,Yau David¹,Mirshahidi Hamid²,Guadiz Tricia³,Zuppan Craig W.¹,Magaki Shino¹^ORCID

Affiliation:

1. Department of PathologyLoma Linda University Medical Center and School of MedicineLoma Linda California USA

2. Department of Internal Medicine, Division of Hematology‐OncologyLoma Linda University Medical Center and School of MedicineLoma Linda California USA

3. Department of Internal MedicineLoma Linda University Medical Center and School of MedicineLoma Linda California USA

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pin.12918

Reference5 articles.

1. AA Amyloidosis: Pathogenesis and Targeted Therapy

2. Amyloidosis and Lung Cancer

3. Nephrotic Syndrome Associated with Lung Cancer: A Rare Case of Malignancy Associated with AA Amyloidosis

4. Fatal gastrointestinal hemorrhage in a paraplegic man with undiagnosed AA (secondary) amyloidosis

5. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Onconephrology: mitigation of renal injury in chemotherapy administration;Current Opinion in Nephrology & Hypertension;2023-12-14

2. Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022;International Journal of Clinical Oncology;2023-07-16

3. Lung cancer combined with diffuse peritoneal and mesenteric amyloidosis detected on 18F-FDG PET/CT;Medicine;2021-05-28

4. Apixaban/nivolumab;Reactions Weekly;2020-06